Quick 2 read update on indications of CAR-T in blood disorders by @ASTCT Committee on practice guidelines. Great paper to reference in CAR manuscript introductions and to quote in painful peer-to-peer reviews #CART 🙏@abe_seb_kanate
https://t.co/IaQksOiVQQ
1/x @ASTCT Committee on Practice Guidelines releases Clinical Practice Recommendations for HCT and CAR-T in DLBCL #lymsm#bmtsm#CART
Open Access (on paywall) @ASTCT_Journal 🙏🙏🙏
https://t.co/HuU05E6lsc
Check out poster by @larissabrunaldi, visiting researcher from Brazil, presents data from @MayoCancerCare study of 161 myeloma pts treated with #CART that bone marrow and PET MRD negativity is prognostic for early relapse vs prolonged PFS #mmsm#ASCO23
@Rfonsi1 Thanks for the shout-out, Dr. Fonseca! Would be great if ASCO and other meetings with large international participation would allow interpreters for more engaged Q&A. It’s another aspect of DEI for our scientific community.
I heard yesterday that a presenter from China at #ASCO23 was struggling to answer questions due to language barriers, after she did an excellent presentation. Dr. @YiLinMDPhD stepped in and said: “I’m here to translate.” Well done!
My theme, “Partnering w patients, the cornerstone of clinical care and research” builds on my career of more than 30 yrs & resonates w many of the challenges in oncology today. The theme promotes the preeminence of the relationship btwn pts & the oncology clinician #ASCO23